Subsequently, we performed immunohistochemistry staining for FOSL1 and NF-κB p65 utilizing rabbit polyclonal antibodies against FOSL1 and NF-κB p65 in glioma tissue microarrays (TMA) obtained from 141 glioma patients and 15 healthy controls. This evidence concerns the gene FOSL1 and central nervous system cancer.